In 2023, actual data indicated 53.73 thousand male deaths from trachea, bronchus, or lung malignant neoplasms in Japan. Forecast data from 2024 to 2028 signals slight, yet consistent, increases in mortality. The year-on-year variation remains close to 0.3% annually. By 2028, projections estimate 54.53 thousand deaths, demonstrating a subtle upward trajectory with a five-year CAGR of approximately 0.3%.

Future trends to watch for:

Advances in medical research and treatment options that could potentially reduce mortality rates.
Influence of lifestyle changes such as reduced smoking rates and air quality improvements.
Impacts of aging population dynamics on health service demands and cancer prevalence.